De-escalation of tyrosine kinase inhibitor therapy before complete treatment discontinuation in patients with chronic myeloid leukaemia (DESTINY): a non-randomised, phase 2 trial
Titel:
De-escalation of tyrosine kinase inhibitor therapy before complete treatment discontinuation in patients with chronic myeloid leukaemia (DESTINY): a non-randomised, phase 2 trial
Auteur:
Clark, Richard E Polydoros, Fotios Apperley, Jane F Milojkovic, Dragana Rothwell, Katherine Pocock, Christopher Byrne, Jennifer de Lavallade, Hugues Osborne, Wendy Robinson, Lisa O'Brien, Stephen G Read, Lucy Foroni, Letizia Copland, Mhairi